INNER MONGOLIA FURUI MEDICAL SCIENCE CO., LTD. Financials Inner Mongolia Furui Medical Science Co., Ltd.
Equities
300049
CNE100000KG1
Advanced Medical Equipment & Technology
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 52.02 CNY | -3.09% |
|
+2.00% | +19.34% |
Valuation
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Capitalization 1 | 2,092 | 3,768 | 6,426 | 11,466 | 13,684 | - | - |
| Enterprise Value (EV) 1 | 2,092 | 3,768 | 6,426 | 11,466 | 13,684 | 13,684 | 13,684 |
| P/E ratio | 33.7 x | 37.4 x | 65.4 x | 113 x | 67 x | 46.1 x | 31.6 x |
| Yield | - | - | - | - | 1.13% | 2.08% | - |
| Capitalization / Revenue | - | - | - | 9.94 x | 8.64 x | 6.39 x | 5.06 x |
| EV / Revenue | - | - | - | 9.94 x | 8.64 x | 6.39 x | 5.06 x |
| EV / EBITDA | - | - | - | - | 38.2 x | 26.1 x | - |
| EV / FCF | - | - | - | 96.9 x | -1,368 x | 124 x | 43.9 x |
| FCF Yield | - | - | - | 1.03% | -0.07% | 0.8% | 2.28% |
| Price to Book | - | - | - | 7.2 x | 7.99 x | 6.99 x | 6.61 x |
| Nbr of stocks (in thousands) | 256,335 | 256,335 | 263,053 | 263,053 | 263,053 | - | - |
| Reference price 2 | 8.160 | 14.70 | 24.43 | 43.59 | 52.02 | 52.02 | 52.02 |
| Announcement Date | 2/26/21 | 2/25/22 | 2/28/23 | 2/29/24 | - | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | - | - | - | 1,154 | 1,583 | 2,140 | 2,704 |
| EBITDA 1 | - | - | - | - | 358 | 525 | - |
| EBIT 1 | - | - | - | 253.1 | 452.3 | 673.3 | 871 |
| Operating Margin | - | - | - | 21.94% | 28.57% | 31.46% | 32.22% |
| Earnings before Tax (EBT) 1 | - | - | - | 235.4 | 442.3 | 663.3 | 859 |
| Net income 1 | 62 | 102.1 | 98.34 | 101.6 | 204 | 308.7 | 433 |
| Net margin | - | - | - | 8.8% | 12.89% | 14.42% | 16.02% |
| EPS 2 | 0.2419 | 0.3930 | 0.3738 | 0.3861 | 0.7767 | 1.128 | 1.645 |
| Free Cash Flow 1 | - | - | - | 118.4 | -10 | 110 | 312 |
| FCF margin | - | - | - | 10.26% | -0.63% | 5.14% | 11.54% |
| FCF Conversion (EBITDA) | - | - | - | - | - | 20.95% | - |
| FCF Conversion (Net income) | - | - | - | 116.57% | - | 35.64% | 72.06% |
| Dividend per Share 2 | - | - | - | - | 0.5900 | 1.080 | - |
| Announcement Date | 2/26/21 | 2/25/22 | 2/28/23 | 2/29/24 | - | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2022 S1 |
|---|---|
| Net sales | - |
| EBITDA | - |
| EBIT | - |
| Operating Margin | - |
| Earnings before Tax (EBT) | - |
| Net income 1 | 32.55 |
| Net margin | - |
| EPS 2 | 0.1237 |
| Dividend per Share | - |
| Announcement Date | 8/28/22 |
1CNY in Million2CNY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - | - | - |
| Net Cash position | - | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - |
| Free Cash Flow 1 | - | - | - | 118 | -10 | 110 | 312 |
| ROE (net income / shareholders' equity) | - | - | - | 6.41% | 12% | 16.3% | 21.7% |
| ROA (Net income/ Total Assets) | - | - | - | - | 8.25% | 10.5% | 15% |
| Assets 1 | - | - | - | - | 2,473 | 2,954 | 2,887 |
| Book Value Per Share 2 | - | - | - | 6.050 | 6.510 | 7.450 | 7.870 |
| Cash Flow per Share 2 | - | - | - | 1.160 | 0.5400 | 1.280 | 2.140 |
| Capex 1 | - | - | - | 186 | 160 | 167 | 221 |
| Capex / Sales | - | - | - | 16.16% | 10.13% | 7.82% | 8.16% |
| Announcement Date | 2/26/21 | 2/25/22 | 2/28/23 | 2/29/24 | - | - | - |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
52.02
Average target price
-
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +19.34% | 1.95B | |
| -15.43% | 18.51B | |
| -40.81% | 2.85B | |
| +2.22% | 1.72B | |
| +28.27% | 1.26B | |
| -9.56% | 1.02B | |
| -16.29% | 950M | |
| +0.07% | 777M | |
| -22.49% | 643M | |
| +11.79% | 518M |
- Stock Market
- Equities
- 300049 Stock
- Financials Inner Mongolia Furui Medical Science Co., Ltd.